title: Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report.
abstract: Orally-administered cholera vaccine (OCV) has been increasingly examined as an additional tool to intervene against endemic and epidemic cholera. In 2013, short- and long-term field experience with OCV under nine distinctive field settings was reported from India, Bangladesh, Vietnam, Guinea, Haiti, and Thailand. Lead investigators from each of these projects presented their findings at a symposium chaired by Drs. David A. Sack and Robert H. Hall at the Vaccines for Enteric Diseases (VED) Conference in Bangkok on November 7, 2013. The objective of the symposium was to describe the unique features of each setting and project, share field experience of implementing cholera vaccination, discuss results, and identify constraints to the wider use of OCV. The VED provided a forum where >200 attendees engaged with this exciting and potentially decisive new development in the cholera field.
authors.affiliation: National Institute for Allergy and Infectious Diseases, Bethesda, MD, USA. Electronic address: robert.hall@nih.gov.
authors.forename: Robert H
authors.initials: RH
authors.lastname: Hall
authors.affiliation: Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
authors.forename: David A
authors.initials: DA
authors.lastname: Sack
mesh_terms: D000284:Administration, Oral; D000349:Africa; D001208:Asia; D002771:Cholera / Q000453:epidemiology* / Q000517:prevention & control*; D022121:Cholera Vaccines / Q000008:administration & dosage* / Q000276:immunology; D002986:Clinical Trials as Topic; D006205:Haiti; D006801:Humans; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods
chemical_list: D022121:Cholera Vaccines
keywords: Acceptability; Cholera; Cholera vaccination; Feasibility; Oral vaccine; Vaccine demonstration; Vaccine stockpile